213915-68-5

Upstream product

• 164228-46-0 (6S,6aR,9R,10aR)-3-(1,1-Dimethyl-heptyl)-9-hydroxymethyl-6-(3-hydroxy-propyl)-6-methyl-6a,7,8,9,10,10a-hexahydro-6H-benzo[c]chromen-1-ol 
• 182509-23-5 (1R,4R,5R)-4-(2,6-dihydroxy-4-(2-methyloctan-2-yl)phenyl)-6,6-dimethylbicyclo[3.1.1]heptan-2-one 
• 213915-85-6 (1R,9R,12R)-5-(1,1-Dimethyl-heptyl)-12-(3-hydroxy-1-methylene-propyl)-8-oxa-tricyclo[7.3.1.0^2,7]trideca-2⁽⁷⁾,3,5-triene-3,9-diol 
• 213915-86-7 (6S,6aR,9R,10aR)-3-(1,1-Dimethyl-heptyl)-6-(2-hydroxy-ethyl)-6-methyl-6a,7,8,9,10,10a-hexahydro-6H-benzo[c]chromene-1,9-diol 
• 213915-88-9 [(6S,6aR,10aR)-1-Allyloxy-3-(1,1-dimethyl-heptyl)-6-methyl-9-oxo-6a,7,8,9,10,10a-hexahydro-6H-benzo[c]chromen-6-yl]-acetaldehyde 
• 213915-87-8 (6S,6aR,9R,10aR)-1-Allyloxy-3-(1,1-dimethyl-heptyl)-6-(2-hydroxy-ethyl)-6-methyl-6a,7,8,9,10,10a-hexahydro-6H-benzo[c]chromen-9-ol 
• 213915-89-0 (6S,6aR,10aR)-1-Allyloxy-3-(1,1-dimethyl-heptyl)-6-((E)-3-methoxy-allyl)-9-[1-methoxy-meth-(Z)-ylidene]-6-methyl-6a,7,8,9,10,10a-hexahydro-6H-benzo[c]chromene 
• 213915-90-3 3-[(6S,6aR,9R,10aR)-1-Allyloxy-3-(1,1-dimethyl-heptyl)-9-hydroxymethyl-6-methyl-6a,7,8,9,10,10a-hexahydro-6H-benzo[c]chromen-6-yl]-propan-1-ol 
• 213915-73-2 (1R,4R,5R)-4-[2,6-Bis-(tert-butyl-dimethyl-silanyloxy)-4-(1,1-dimethyl-heptyl)-phenyl]-6,6-dimethyl-bicyclo[3.1.1]heptan-2-one 
• 213915-71-0 (3R,4R)-3-[2,6-Bis-(tert-butyl-dimethyl-silanyloxy)-4-(1,1-dimethyl-heptyl)-phenyl]-4-isopropenyl-cyclohexanone 
• 213915-84-5 (3R,4R)-3-[2,6-Bis-(tert-butyl-dimethyl-silanyloxy)-4-(1,1-dimethyl-heptyl)-phenyl]-4-(3-hydroxy-1-methylene-propyl)-cyclohexanone 
• 213915-92-5 (6S,6aR,9R,10aR)-1-Allyloxy-3-(1,1-dimethyl-heptyl)-6-methyl-6-(3-oxo-propyl)-6a,7,8,9,10,10a-hexahydro-6H-benzo[c]chromene-9-carbaldehyde 

Relevant academic research and scientific papers

Classical/nonclassical hybrid cannabinoids: Southern aliphatic chain- functionalized c-6β methyl, ethyl, and propyl analogues

The stereoelectronic requirements for interaction of the southern aliphatic hydroxyl of cannabimimetic pharmacophores with the CB1 and CB2 receptors are explored. The stereoselective syntheses of three series of classical/nonclassical hybrid cannabinoids